Abstract
In Fabry disease, accumulation of globotrianosylceramide and galabiosylceramide are observed by coloration methods associated to optic or electron microscopy. But a new technology, imaging mass spectrometry, may be applied to the analysis of these metabolites in tissue of hemizygous patients with Fabry disease. Advantages and disavantadges of this technic are discussed.
| Translated title of the contribution | Imaging mass spectrometry and direct analysis of globotriaosylceramide and galabiosylceramide in tissue |
|---|---|
| Original language | French |
| Pages (from-to) | 55-56 |
| Number of pages | 2 |
| Journal | Medecine/Sciences |
| Volume | 21 |
| Issue number | SPEC. ISS. NOV. |
| DOIs | |
| Publication status | Published - 1 Jan 2005 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Imaging mass spectrometry and direct analysis of globotriaosylceramide and galabiosylceramide in tissue'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver